Up a level |
Morton, B ORCID: 0000-0002-6164-2854, Mitsi, E, Pennington, SH, Reine, J, Wright, AD, Parker, R, Welters, ID ORCID: 0000-0001-8734-994X, Blakey, JD ORCID: 0000-0003-2551-8984, Rajam, G, Ades, EW et al (show 4 more authors)
(2016)
AUGMENTED PASSIVE IMMUNOTHERAPY WITH P4 PEPTIDE IMPROVES PHAGOCYTE ACTIVITY IN SEVERE SEPSIS.
SHOCK, 46 (6).
pp. 635-641.
Mitsi, E, Roche, AM, Reine, J, Zangari, T, Owugha, JT, Pennington, SH, Gritzfeld, JF, Wright, AD, Collins, AM ORCID: 0000-0002-4094-1572, van Selm, S et al (show 4 more authors)
(2017)
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.
MUCOSAL IMMUNOLOGY, 10 (2).
pp. 385-394.
Pennington, SH, Pojar, S, Mitsi, E, Gritzfeld, JF, Nikolaou, E, Solorzano, C, Owugha, JT, Masood, Q, Gordon, MA ORCID: 0000-0002-0629-0884, Wright, AD et al (show 4 more authors)
(2016)
Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 194 (12).
pp. 1523-1531.
German, EL, Solorzano, C, Sunny, S, Dunne, F, Gritzfeld, JF, Mitsi, E, Nikolaou, E, Hyder-Wright, AD, Collins, AM, Gordon, SB et al (show 1 more authors)
(2019)
Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density.
VACCINE, 37 (30).
pp. 3953-3956.